Inquiry
Prospect submits the qualification form with territory, role, budget, timeline, and platform scope.
This page screens inbound interest, captures qualification data, and routes qualified prospects into a staged confidential review path.
Commercial terms remain indicative until diligence, territory scope, and protection posture are reviewed. One filed core technology is currently patent-pending in Canada; additional proprietary systems remain confidential.
Presenting the process clearly reduces repetitive questions and shows prospective partners how engagement progresses before direct contact.
Prospect submits the qualification form with territory, role, budget, timeline, and platform scope.
Qualified counterparties execute the confidentiality agreement to initiate controlled review before any deeper release.
After signature, you review the submission, score the lead, and decide whether to advance or decline.
Authorized counterparties receive strategic, technical, or commercial access based on diligence stage and seriousness.
Territory structure, economics, and implementation pathway are reviewed under controlled disclosure.
Serious counterparties move to term sheet, agreement drafting, and closing.
Share your territory, role, and commercialization intent. Qualified counterparties are guided into the NDA path for review, signature, and controlled follow-through.
These are the questions that tend to consume time during early-stage outreach. Handle them on-site so only qualified prospects keep moving.
How country rights work, whether exclusivity is possible, and how territory scope is assessed.
How indicative economics are framed, what remains negotiable, and when final commercial terms are discussed.
Why deeper materials are gated, what happens after NDA, and what technical support looks like later.
All public materials are illustrative, non-enabling, and do not define claim scope. Nothing herein constitutes a complete technical disclosure of any system, method, or invention. Zelta AeroSystems reserves all rights to undisclosed embodiments, variations, and future filings.